Michael Marchick, M.D.
Interim Vice-Chair Of Education; Associate Professor; Assistant Program Director, Residency; Vice Chair, Clinical Operations
Department:
Department of Emergency Medicine
Business Phone:
(352) 265-5911
About Michael Marchick
Dr. Marchick joined the UF faculty in 2010 following the completion of an Emergency Medicine Research Fellowship at Carolinas Medical Center in Charlotte. Prior to fellowship, Dr. Marchick graduated from Duke with a B.S. in Chemistry, received his M.D. from the University of Pittsburgh, and completed his residency in Emergency Medicine at Carolinas.
Dr. Marchick’s research interests focus on pulmonary embolism. He has been a co-investigator on several clinical trials for PE and conducts basic science research into the pathophysiology of acute pulmonary hypertension resulting from PE.
Teaching Profile
Courses Taught
2016,2018
MDC7710 Sr Emerg Med Clerkshp
2018
MDT7090 Elective Topics
Board Certifications
-
Emergency MedicineAmerican Board of Emergency Medicine
Clinical Profile
Specialties
- Emergency Medicine
Areas of Interest
- High blood pressure – adults
- Pulmonary embolus
Research Profile
Areas of Interest
- pulmonary embolism
- acute pulmonary hypertension resulting from pulmonary embolism
Publications
2019
A case of refractory ventricular fibrillation successfully treated with low-dose esmolol.
BMJ case reports.
12(3)
[DOI] 10.1136/bcr-2018-228208.
[PMID] 30852502.
2019
Estimates of radiation exposure and subsequent risk of malignancy due to cardiac imaging in the emergency department for evaluation of chest pain: a cohort study.
Coronary artery disease.
30(8):626-628
[DOI] 10.1097/MCA.0000000000000806.
[PMID] 31577617.
2017
Comparison of 3 Symptom Classification Methods to Standardize the History Component of the HEART Score.
Critical pathways in cardiology.
16(3):102-104
[DOI] 10.1097/HPC.0000000000000119.
[PMID] 28742646.
2016
The incidence and significance of acute kidney injury following emergent contrast administration in patients with STEMI and stroke.
Internal and emergency medicine.
11(6):853-7
[DOI] 10.1007/s11739-016-1407-9.
[PMID] 26910240.
2014
Dyspnea, tachycardia, and new onset seizure as a presentation of wilms tumor: a case report.
Case reports in emergency medicine.
2014
[DOI] 10.1155/2014/562672.
[PMID] 24851188.
2013
Evaluation of C-Reactive Protein Levels in the Diagnosis of Acute Pulmonary Embolism
Annals of Emergency Medicine.
62
2012
Prospective study of the frequency and outcomes of patients with suspected pulmonary embolism administered heparin prior to confirmatory imaging.
Thrombosis research.
129(4):e25-8
[DOI] 10.1016/j.thromres.2012.01.005.
[PMID] 22285109.
2011
Effects of angiotensin (1-7) upon right ventricular function in experimental rat pulmonary embolism.
Histology and histopathology.
26(10):1287-94
[DOI] 10.14670/HH-26.1287.
[PMID] 21870332.
2011
Up-regulation of arginase II contributes to pulmonary vascular endothelial cell dysfunction during experimental pulmonary embolism.
Pulmonary pharmacology & therapeutics.
24(4):407-13
[DOI] 10.1016/j.pupt.2011.01.009.
[PMID] 21281730.
2010
12-lead ECG findings of pulmonary hypertension occur more frequently in emergency department patients with pulmonary embolism than in patients without pulmonary embolism.
Annals of emergency medicine.
55(4):331-5
[DOI] 10.1016/j.annemergmed.2009.07.025.
[PMID] 19766353.
2010
Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
50(6):814-20
[DOI] 10.1086/650580.
[PMID] 20144044.
2010
Rapid clearance of circulating haptoglobin from plasma during acute pulmonary embolism in rats results in HMOX1 up-regulation in peripheral blood leukocytes.
Journal of thrombosis and haemostasis : JTH.
8(2):389-96
[DOI] 10.1111/j.1538-7836.2009.03704.x.
[PMID] 19943874.
2010
Right ventricular heart failure from pulmonary embolism: key distinctions from chronic pulmonary hypertension.
Journal of cardiac failure.
16(3):250-9
[DOI] 10.1016/j.cardfail.2009.11.008.
[PMID] 20206901.
2009
One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study.
Critical care (London, England).
13(5)
[DOI] 10.1186/cc8138.
[PMID] 19845956.
2009
Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure.
Chest.
136(5):1202-1210
[DOI] 10.1378/chest.08-2988.
[PMID] 19542256.
2009
Reduction in plasma haptoglobin in humans with acute pulmonary embolism causing tricuspid regurgitation.
Journal of thrombosis and haemostasis : JTH.
7(9):1597-9
[DOI] 10.1111/j.1538-7836.2009.03535.x.
[PMID] 19566548.
2009
The significance of non-sustained hypotension in emergency department patients with sepsis.
Intensive care medicine.
35(7):1261-4
[DOI] 10.1007/s00134-009-1448-x.
[PMID] 19238354.
2008
Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism.
American heart journal.
156(2):308-14
[DOI] 10.1016/j.ahj.2008.03.026.
[PMID] 18657661.
2001
A protective role for cyclooxygenase-2 in drug-induced liver injury in mice.
Chemical research in toxicology.
14(12):1620-8
[PMID] 11743745.
1999
Immunochemical evidence against the involvement of cysteine conjugate beta-lyase in compound A nephrotoxicity in rats.
Anesthesiology.
90(2):458-69
[PMID] 9952153.
1999
Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
Chemical research in toxicology.
12(2):214-22
[PMID] 10027801.
Grants
Feb 2022
ACTIVE
CTOA
Role: Principal Investigator
Funding: UNIV OF FLORIDA
Apr 2016
– Mar 2022
UTILIZATION OF TICAGRETOR IN THE UPSTREAM SETTING FOR NSTE ACUTE CORONARY SYNDROME (UPSTREAM)
Role: Principal Investigator
Funding: HOSPITAL QUALITY FOUNDATION
via ASTRAZENECA
May 2015
– May 2018
D-Dimer DVT/PE Exclusionary sample collection project
Role: Principal Investigator
Funding: SIEMENS HEALTHCARE DIAGNOSTICS INC
Mar 2015
– Mar 2018
A Phase III, clinical study of the reversal of the anticoagulant effects of dabigatran by intravenous administration of 5.0 g idarucizumab (BI 655075) in patients treated with dabigatran etexilate who have uncontrolled bleeding… RE-VERSE-AD) trial
Role: Principal Investigator
Funding: BOEHRINGER INGELHEIM PHARM INC
Education
Residency – Emergency Medicine
2008
·
Carolinas Medical Center
Medical Degree
2005
·
University of Pittsburgh
Bachelor of Science
2000
·
Duke University
Contact Details
Phones:
- Business:
- (352) 265-5911
Addresses:
- Business Mailing:
-
PO Box 100186
GAINESVILLE FL 32610 - Business Street:
-
1329 SW 16th Avenue
GAINESVILLE FL 32608